PharmaVOICE - 
October 2020
Purchase Issue
In Every Issue
Letter from the Editor
Is the industry ready for an AI revolution? We hooked [...]
By

Taren Grom, Editor

Upfront
Takeda’s Innovators in Science Award Takeda Pharmaceuticals and the New [...]
By

PharmaVOICE Staff

HealthTech
Organ-on-a-Chip Transforms Drug Development Trend Watch: Healthtech Applications Run the [...]
By

PharmaVOICE Staff

Artificial Intelligence
BenevolentAI Validates Baricitinib as Treatment for COVID-19 Trend Watch: AI [...]
By

PharmaVOICE Staff

Last Word
The Impact Of COVID-19 On The Workplace Laurie Cooke, President [...]
By

Laurie Cooke, President and CEO of the Healthcare Businesswomen’s Association (HBA)

On The Cover

Creative Executions
Creative thinking inspires ideas. Ideas inspire change. — Barbara Januszkiewicz In the new-ish omnichannel world of advertising that includes print, TV, social media, etc., great creative based on great ideas, good data, and a fearless approach to ideation is the lynchpin that leads to great campaigns that move and motivate audiences — patients and healthcare [...]
By

Taren Grom, Editor

Features

Commercial Influencers
Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. According to the global consultancy Evaluate, the impact of COVID-19 has so far wiped .85 billion off forecasts for biopharma sales in 2020, with the top 15 companies bearing 60% of that loss. However, [...]
By

PharmaVOICE Staff

Roshawn Blunt — Optimizing a Strategic Plan
Given cell and gene therapies are typically personalized medicines, they come with outlier pricing and other unique commercialization challenges that differ from other large and small molecule therapies. Roshawn Blunt, a respected biotech consultant, was inspired by President John Adams, who in 1798 signed an act authorizing the deduction of 20 cents per month from [...]
By

Roshawn Blunt, Managing Director, 1798 Consultants, a Fingerpaint company

Greg Skalicky — Understanding the Commercial Lifecycle
By building a complete commercial platform, we are able to take a broad view of how market and product complexities impact operations. With a wide breadth of clinical and commercial experience, Greg Skalicky, chief revenue officer of EVERSANA, has a keen understanding of the entire product lifecycle and recognizes the increasing importance of getting commercialization [...]
By

Greg Skalicky, Chief Revenue Officer, EVERSANA

SHOWCASE: Artificial Intelligence: Driving Drug Innovation With AI
The global AI market has been showing rapid growth as major pharmaceutical and medical technology companies invest heavily in internal and external AI partnerships. According to some reports, more than 50% of executives expect broad scale AI adoption by 2025. Further, revenue generated through AI-based solutions in the industry is projected to rise at a [...]
By

PharmaVOICE Staff

Case Study: Leveraging AI for Meaningful Clinical Trials
Clinical trial sponsors seeking to develop new drugs and therapies face unique challenges, particularly when it comes to understanding patient dosing and response to therapy. This aspect can be difficult, as patients often: Do not take their medicine regularly, or at all Take creative measures to hide their non-adherence Have symptoms that make it difficult [...]
By

Rich Christie, M.D., Ph.D., Chief Development Officer, AiCure

How AI Can Improve Understanding of Patient’s Behavior and Symptoms
Running and managing clinical trials, at the most basic level, is about creating a foundation to get the best possible data. While a great deal of thought goes into recruiting the right patients and developing the most effective protocols, initiatives designed to improve the experience for the patients while at the same time gathering cleaner, [...]
By

Michelle Marlborough, Chief Product Officer, AiCure

5 Steps to Intelligent Omnichannel Engagement
The future of HCP engagement in the post-pandemic world isn’t clear. But in the wake of pharma’s forced digital migration, the need for an effective omnichannel strategy is. Luckily, most commercial teams already have a strong data and analytics infrastructure in place and are beginning to activate non-personal channels at scale. But for an industry [...]
By

Matthew Van Wingerden, GM Advanced Services, Aktana

Technology-Driven Pharmacovigilance Operations
Improving Data Quality and Compliance while Reducing Cost with AI Traditionally, the pharmacovigilance (PV) function has been responsible for collecting, assessing, and reporting safety information to health authorities, sites, and other stakeholders. Companies have invested in safety systems to gather, organize, and search data. Yet, these closed systems often have lacked the real-time integration and [...]
By

Dinesh Kasthuril, Head of Global Client Relations & Project Management, Patient Safety Solutions, Covance

AI and Drug Discovery
Discovering and bringing new drugs to market is notoriously slow and costly for a reason. Science moves slowly because of the incredibly complex nature of human biology and the difficulty of sluggish recruitment of clinical trials. And in spite of greater investments in R&D by pharmaceutical companies, the number of new drug approvals has declined. [...]
By

Claire Bonaci, Senior Director, US Health and Life Sciences, Microsoft

The Accessibility of AI: Innovation at Your Fingertips
The availability of datasets keeps growing exponentially. With this we are witnessing an escalation of available new life-altering systems. Some of these tools are highly autonomous and can perform functions with little to no human intervention. Self-driving cars, rockets that land upright on drone ships, computers that write poetry and perform their own music, tireless [...]
By

Max Divak,Interactive Group Supervisor, Ogilvy Health

AI-Driven Marketing
We have all seen those digital banners that are somehow related to what we’re looking at online and appear to follow us wherever we are. Don’t worry, there is nothing ominous at play and the government is not listening to our conversations through our devices. But this is not completely coincidental either. Those “timely” and [...]
By

J.P. Maranzani, VP, Account Group Supervisor - Point of Care Practice (EHR/ABM), Ogilvy Health

Leveraging AI to Slingshot Drugs from Lab to Market
The science of clinical development continually astounds even those of us intimately connected to it. We recognize that our overarching industry mandate — to develop and deliver safe and effective new therapies to fight and cure disease — must be continually informed by new thinking and tools if we are to realize not just incremental, [...]
By

Malai Sankarasubbu, VP of AI Research, Saama Technologies

The Salesforce of the Future
COVID-19 is fast-tracking the industry’s slow move from fewer in-person HCP visits to digital and virtual approaches. COVID-19 has driven vast changes in what healthcare providers need and value from pharma companies, and as a result, the industry is striving to develop new ways to engage with physicians. Experts say this is just the beginning [...]
By

Robin Robinson

SHOWCASE: Patient Solutions: The Changing Face of Patient Engagement
Digital technologies are changing the healthcare landscape, creating opportunities for patient-support programs, patient monitoring and self-management. There is massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach .36 billion by 2026. In addition, the rising incidence of chronic diseases and government efforts to create awareness about engagement solutions have [...]
By

PharmaVOICE Staff

Advancing Beyond the Traditional Patient Adherence Model
Delivering value in the era of empowered patients renders the one-size-fits-all patient services program obsolete. Not every treatment journey is consistently linear within a disease state because patients take different paths to medication adherence. For example, one patient may be compliant when prompted by a smartphone notification, while another patient relies on a caregiver for [...]
By

Maria Kirsch, Senior VP, Head of Patient Services, EVERSANA

Social Connection Is Possible in a Time of Physical Distancing
In this time of physical distancing, technology often seems like the go-to solution for helping people connect. However, data linking social media and depression, as well as research pointing to social divisiveness online, might give us pause. Recent survey results found most Americans believe that Internet and technology companies are doing more to create divisiveness [...]
By

Amrita Bhowmick, Chief Community Officer, Health Union

Listening to the Patient for Better Outcomes
The aim of drug development is to improve patient outcomes. Historically, clinical research has been driven by researchers, with little or no input from patients, contributing to many of the challenges and inefficiencies we see in today’s clinical trials. Some of these challenges include low enrolment and retention rates, in addition to poor engagement. Implementing [...]
By

Gretchen Goller, Global Head, Patient Recruitment and Retention Solutions, ICON

Site Unseen? Virtual and Hybrid Trials the Way of the Future
Decentralized trials create new opportunities for reaching more patients and safeguarding them during a pandemic, but what do they mean for sites? The clinical trial landscape has been going through a period of rapid and profound change. Even before the COVID-19 pandemic, trial sites have faced multiple challenges — from financial pressures, to patient recruitment, [...]
By

Kim Ribbink

Speak Out: The Power of Virtual Patient Simulation in CME
Simulation as we think of it today has been used in medical education since the 18th century,1 and has continued to evolve into realistic and medically accurate physical and digital solutions designed to allow learners to simulate a scenario-based encounter with a patient in a safe environment. Virtual Patient Simulations Virtual patient simulation is an [...]
By

Martin Warters, MA Ed. Tech, CHSE, Director, Learner Experience and Instructional Design, Medscape

Executive Perspective: AI With a Healthcare IQ: A Conversation with Lucas Glass and Andrew Ploszay
Since the term was first coined in 1955, “artificial intelligence” (AI) has led to significant advances across industries. From robotics to automobiles, to digital personal assistants, and even online shopping. In healthcare, AI has enabled many successes, but a few noteworthy failures have made some companies question how they should apply AI to their clinical [...]
By

Lucas Glass, Global Head, Analytics Center of Excellence, IQVIA and Andrew Ploszay, VP, Digital Strategy, IQVIA

FEEDBACK